Kolon TissueGene
Kolon Tissuegene develops cell and gene therapy for osteoarthritis diseases such as knees, spine and hip joints, and you can browse investment and company information on this site.
Basic Information
- Category: business
- Website: https://www.tissuegene.com/
Documented Facts
- Inception (Wikidata): 1999-06-09 (Source 2: Wikidata Q131188622, revision 2548296110)
- Industry (Wikidata; date unspecified): biotechnology (Source 2: Wikidata Q131188622, revision 2548296110; Source 3: Wikidata label: Q7108, revision 2554192905)
- Legal form (Wikidata; date unspecified): corporation (Source 2: Wikidata Q131188622, revision 2548296110; Source 4: Wikidata label: Q57655560, revision 2510799730)
- Headquarters location (Wikidata; date unspecified): Rockville (Source 2: Wikidata Q131188622, revision 2548296110; Source 5: Wikidata label: Q327022, revision 2530086847)
- Country (Wikidata; date unspecified): United States (Source 2: Wikidata Q131188622, revision 2548296110; Source 6: Wikidata label: Q30, revision 2556188301)
Evidence and Sources
- Kolon TissueGene — Official Site (official)
- Wikidata Q131188622, revision 2548296110 (knowledge-base)
- Wikidata label: Q7108, revision 2554192905 (knowledge-base)
- Wikidata label: Q57655560, revision 2510799730 (knowledge-base)
- Wikidata label: Q327022, revision 2530086847 (knowledge-base)
- Wikidata label: Q30, revision 2556188301 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Kolon TissueGene.
- Canonical profile: https://brandsource.ai/brands/kolon-tissuegene
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/kolon-tissuegene/json-ld
- Citation profile API: https://brandsource.ai/api/brands/kolon-tissuegene/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Kolon Tissuegene develops cell and gene therapy for osteoarthritis diseases such as knees, spine and hip joints, and you can browse investment and company information on this site.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 5 supporting sources linked.
- 5 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.